MeekooDharMD

Oncology • Staten Island, NY

Hematologic Oncology

Physician

Join to view full profile

Dr. Dhar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dhar's full profile

Already have an account?

Office
256C Mason Avenue
Staten Island, NY 10305
Phone+1 718-226-6400

Fax+1 718-226-6404

Education & Training

New York-Presbyterian Brooklyn Methodist HospitalFellowship, Hematology and Medical Oncology, 2000 - 2003
New York-Presbyterian Brooklyn Methodist HospitalResidency, Internal Medicine, 1997 - 2000
Government Medical College SrinagarClass of 1996

Certifications & Licensure

NY State Medical License 2000 - 2025
NJ State Medical License 2003 - 2009
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Clinical Trials

Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer Start of enrollment: 2008 Jul 30
Completed
Phase 2
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer Start of enrollment: 2008 Oct 13
Completed
Phase 3
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery Start of enrollment: 2009 May 15
Active, not recruiting
Phase 2
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer Start of enrollment: 2009 Aug 17
Active, not recruiting
Phase 3
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16
Completed
Not Applicable
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

5 citations
Expression patterns and clinical significance of estrogen receptor in non-small cell lung cancer.
Mario R Castellanos, Ereeny Fanous, Rina Thaker, Michael J Flory, Nagashree Seetharamu
Pathology, Research and Practice. 2023-01-01
2 citations
Vulvar Cancer with Cutaneous and Breast Metastases.
Nawaraj Adhikari, Adarsh Vennepureddy, Sara Parylo, Anupma Agarwal, Meekoo Dhar
Case Reports in Medicine. 2021-01-18
13 citations
Esophageal Granular Cell Tumor: A Case Report and Review of Literature.
Nishitha Thumallapally, Uroosa Ibrahim, Mayurathan Kesavan, Qing Chang, Lynne Opitz
Cureus. 2016-09-14

Professional Memberships

American Society of Clinical Oncology - ASCO
Member